Lymphangioma Circumscriptum — Trials

Lymphangioma Circumscriptum — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06239480	SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations(SELVA)	active not recruiting	Phase 3	51	Palvella Therapeutics, Inc.INDUSTRY	1	Mar 27, 2026	clinicaltrials
NCT00975819	Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies	completed	Phase 2	61	Denise Martin AdamsOTHER	1	Jan 6, 2026	clinicaltrials
NCT05050149	Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations	completed	Phase 2	12	Palvella Therapeutics, Inc.INDUSTRY	1	Jan 17, 2025	clinicaltrials
NCT06160739	Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations	unknown	—	10

Data updated 22 days agoSource updated Mar 27, 2026source: clinicaltrials